The effect of pre-hospital glycoprotein IIb–IIIa inhibitors on angiographic outcome in STEMI patients who are candidates for primary PCI (pages 956–964)Renicus S. Hermanides, J. Wouter van Werkum, Jan Paul Ottervanger, Nicoline J. Breet, A.T. Marcel Gosselink, K. Gert van Houwelingen, Jan-Henk E. Dambrink, Christian Hamm, Jurrien M. ten Berg and Arnoud W.J. van 't Hof, On behalf of the Ongoing Tirofiban In Myocardial infarction Evaluation (On-TIME) 2 study group
Article first published online: 12 DEC 2011 | DOI: 10.1002/ccd.23165